Mutations in TREM2 or DNAX-activation protein 12 (DAP12) impair both osteoclast activity and microglial function, as observed in Nasu–Hakola disease that presents with bone cysts and early dementia, an archetype of neuroskeletal syndromes [34]. The gene discussed is TYROBP; the disease is bone disorder.